Over the past 7 years, many randomized clinical trials (RCTs) have evaluated vitamin D supplementation for improving primary or secondary outcomes of cardiovascular disease, cancer, diabetes, depression, bone health, and falls, necessitating a reevaluation of whether screening for vitamin D insufficiency might be worthwhile. More
This cohort study assesses strategies to triage patients for mammogram cancer screening during times of reduced capacity. More
Millions of colonoscopies, mammograms, lung scans, Pap tests and other cancer screenings were suspended for several months last spring in the United States and elsewhere as COVID-19 swamped medical care. Now researchers are studying the impact, looking to see how many cancers were missed and whether tumors found since then are more advanced. More
To reduce the incidence, morbidity, and mortality associated with breast cancer, accessible and affordable screening, diagnosis, treatment, and surveillance strategies that balance harms and benefits are needed. More
The government will fund reseach asking whether cancer patients "really do worse because of being diagnosed later" during the pandemic. More
The US Preventive Services Task Force (USPSTF) has reaffirmed its 2014 recommendation3 against screening for asymptomatic carotid artery stenosis in the general adult population (D recommendation) based on an assessment of no benefit and possible harm. More
A new paper calls for a halt to skin cancer screenings in the general population. Some physicians vehemently disagree. More
This cohort study describes the number of patients undergoing cancer screening tests and of ensuing cancer diagnoses during the COVID-19 pandemic in 1 health care system in the northeastern United States. More
An at-home test for colon cancer is as reliable as the traditional screening, health experts say, and more agreeable. More
Widespread COVID testing has revealed uncomfortable truths about medical tests: A test result is rarely a definitive answer, but instead a single clue. More